Hadasit Bio-Holdings

Press Releases - 2006

Dec. 31, 2006  -   IBI Investment Group Issues Coverage Update for HBL
Delivers "Buy" Recomnedation - With Price Target of 9.20 NIS
Dec. 27, 2006  -   ProtAb - Start-Up Profile. Gali Weinreb, "Globes"
Published in Globes
Dec. 25, 2006  -   Israeli BioMed Companies - Year End Summary. Gali Weinreb, "Globes"
Hadasit Bio-Holdings Shows Highest Returns for Class of 2006 IPO's
Dec. 5, 2006  -   Cell Cure Neurosciences Ltd., An HBL Portfolio Company, Receives Important US Patent
Further Strengthening its Neural Patent Estate
Nov. 28, 2006  -   ES Cell International, Cell Cure (an HBL Portfolio Company) and Geron enter into Patent Cross License
Nov. 3, 2006  -   Cell Cure Neurosciences Ltd., a subsidiary of Hadasit Bio-Holdings, Hires Vice-President for R&D, Joins the "Bereshith" Consortium
Oct. 17, 2006  -   Lifesaving Treatment for Stroke Victims Developed by Thrombotech Ltd. : Hadassah-UPenn Team
Thrombotech is a Highly Promising HBL Portfolio Company
Oct. 12, 2006  -   Hebrew University (Jerusalem) Ranked 12th in the World in Biotechnology Patents
Sep. 28, 2006  -   IBI Initiates Coverage of HBL with "Buy" Recommendation
Target Price Over 50% Above Current Price
Sep. 21, 2006  -   HBL Initiates System to Enable Overseas Investment
Sep. 19, 2006  -   Summary at the Bio-Med Sector at TASE - HBL is One of the Promising Companies
Published in "Bizportal" in Hebrew
Sep. 12, 2006  -   Ortec (an HBL Portfolio Company) Announces Positive Results in Confirmatory Venous Leg Ulcer Trial
Pre Market Approval Supplement Application Expected to be Filed with FDA During 4th Quarter
Aug. 30, 2006  -   Hadasit Bio-Holdings Completes Secondary Offering, Raises 42 M NIS in Convertible Bonds
According to Dr. Rafi Hofstein: “Leading institutional investors have expressed their confidence in the company through their participation in this offering.”
Aug. 1, 2006  -   TASE Biotech Stocks Performance During the Armed Conflict
Published in "Bizportal" - in Hebrew
Jul. 23, 2006  -   Hadasit Bio-Holdings to appear in Windows - the Hadassah Magazine
Presented at the Hadassah Conference in Nashville TN.
Jul. 12, 2006  -   Hadasit Bio-Holdings - Innovation Taken Public
HBL To Appear in the Hadassah Annual R&D Publication
Jul. 1, 2006  -   Biotechnology Park to House HBL Offices
BioPark Scheduled to Open in Mid 2007
Jun. 25, 2006  -   TK Signal, a Subsidiary of Hadasit Bio-Holdings, Raises $1.3 million From Private Investors in London
TK Signal, which specializes in the diagnosis and treatment of cancer, raised the money at a pre-money company valuation of $10 million.
Jun. 22, 2006  -   Ortec Initiates Pre-Clinical Animal Model Study to Evaluate Fibrin Microbead Technology for Stem Cell Regeneration of Non-Union Bone Defects
Ortec Recently Acquired Hapto Biotech, an HBL Portfolio Company
Jun. 15, 2006  -   Hadasit Bio-Holdings Invests another NIS 700,000 in Thrombotech, One of its Portfolio Companies
About a month ago, Thrombotech reported new findings at the conclusion of animal trials.
May. 23, 2006  -   Ortec CEO Details Corporate Vision and Mission in Letter to Shareholders
May. 9, 2006  -   Thrombotech Ltd., A Portfolio Company Of Hadasit Bio-Holdings Ltd., Reports New Findings At The Conclusion Of Animal Trials
Apr. 9, 2006  -   HBL - Hadasit Bio-Holdings Ltd. Portfolio Company Announces Merger With Ortec International, Inc.
Mar. 31, 2006  -   ES Cell International Receives Important Us Patent, Further Strengthening Its Neural Portfolio
Mar. 27, 2006  -   ES Cell International Sells Equity In Its Subsidiary, Cell Cure Neurosciences, To Hadasit Bioholdings
Move Will Help Advance Research into Neural Diseases Such as Parkinson’s Disease
Mar. 21, 2006  -   Incure, A Subsidiary Of Hadasit Bio-Holdings, Which Is Developing A Kit For Detection Of Cancer In Blood Samples, Has Been Notified Of The Approval Of Its European Patent
 
 

Press Releases Archive